These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6289565)

  • 1. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R; Schulz E
    Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
    Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rapid determination of the synergy of clavulanic acid and beta lactams by measuring the intracellular ATP by bioluminescence].
    Cornel E; Philippon A; Paul G; Guenounou M
    Ann Microbiol (Paris); 1982; 133(3):365-77. PubMed ID: 6819796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
    Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
    Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies.
    Cullmann W
    Zentralbl Bakteriol; 1991 Oct; 275(4):500-3. PubMed ID: 1661596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antibacterial activity of amoxycillin/clavulanic acid against Staphylococcus aureus ingested by human granulocytes.
    Cuffini AM; Tullio V; Allocco A; Paizis G; Carlone NA
    Microbios; 1996; 87(350):31-8. PubMed ID: 8972100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):582-5. PubMed ID: 6255862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Fass RJ; Prior RB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemical structure, anti-bacterial activity and pharmacokinetics of penicillins].
    Miyashita T; Ono Y; Kunii O
    Nihon Rinsho; 1991 Oct; 49(10):2266-70. PubMed ID: 1660944
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
    Campos M; Alarcón MA; González H; Sánchez R
    Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.